Can u give sturgeon 25 with vertin
Reading File
Asking for Preferences
Finding Sources
Finding Sources
Searching the Web
Stugeron 25 cinnarizine with Vertin betahistine combination vertigo
Reading Web Page
cinnarizine betahistine combination rational vertigo
Finding Sources
Reading File
Here's a comprehensive overview of Stugeron 25 (cinnarizine 25 mg) combined with Vertin (betahistine):
Stugeron 25 (Cinnarizine) + Vertin (Betahistine) — Drug Overview
Individual Mechanisms
| Drug | Class | Mechanism |
|---|---|---|
| Cinnarizine (Stugeron 25) | Calcium channel blocker / H1 antihistamine | Blocks Ca²⁺ channels in vestibular hair cells → reduces sensitivity; also has antihistaminic and anti-dopaminergic effects |
| Betahistine (Vertin 8/16/24 mg) | H1 agonist / H3 antagonist | Increases cochlear and labyrinthine blood flow; decreases peripheral vestibular firing; may facilitate vestibular compensation |
Is the Combination Rational?
Yes — with nuance. The two drugs work via complementary mechanisms, and their combination has been studied, particularly in Ménière's disease (MD).
A PMC-published Italian study (2015) specifically evaluated betahistine + cinnarizine in MD patients poorly responsive to betahistine alone:
- MD with migraine: Vertigo spells reduced from 9.4 → 3.8 (p = 0.0001); headaches reduced from 3.8 → 1.0 (p = 0.0001)
- MD without migraine: Vertigo spells reduced from 6.8 → 5.9 (p = 0.01)
- Combination was particularly effective in MD patients with comorbid migraine, as cinnarizine also acts as a calcium-channel-based migraine prophylactic
Common Clinical Uses
- Ménière's disease — especially when betahistine monotherapy is insufficient
- Peripheral vertigo (labyrinthitis, vestibular neuritis) — short-term symptom relief
- Vestibular migraine — cinnarizine adds migraine prophylaxis value
- Motion sickness — cinnarizine is a classic choice
Dosing
| Drug | Typical Dose |
|---|---|
| Cinnarizine (Stugeron) | 25 mg TDS (three times daily) with food |
| Betahistine (Vertin) | 8–16 mg TDS, or 24 mg BD; up to 48 mg/day is evidence-based |
Precautions for the Combination
- Parkinsonism risk: Cinnarizine has dopamine-blocking activity and can cause or worsen drug-induced parkinsonism, especially with prolonged use or in elderly patients. It should be used at the lowest effective dose and for the shortest duration possible. (Bradley & Daroff's Neurology)
- Anticholinergic burden: Cinnarizine carries a mild anticholinergic load (rated "1" on the anticholinergic burden scale). Combining with other anticholinergic agents increases risk of sedation and confusion.
- Sedation: Both drugs can cause drowsiness — warn patients about driving/operating machinery.
- Avoid in Parkinson's disease: Cinnarizine is contraindicated.
- Pregnancy/breastfeeding: Use with caution; limited safety data.
Bottom Line
Cinnarizine + betahistine is a rational and commonly prescribed combination in vertigo/Ménière's, particularly when single-agent therapy is inadequate. The combination is especially beneficial in patients with vestibular migraine comorbidity. However, keep cinnarizine use short-term to minimize extrapyramidal side effects.
Tintinalli's Emergency Medicine notes: "Calcium channel blockers [cinnarizine] are indicated for symptomatic relief of vertigo in patients not responding to scopolamine or antihistamines" as second-line therapy.
This is a shared conversation. Sign in to Orris to start your own chat.